[Malignant maxillofacial extra-nodal lymphoma].
64 patients with extra-nodal maxillo-facial NHL were seen between 1969 and 1989. These rare tumours (1 to 4% of stomatological tumours) tended to occur more often in men (60% of cases) between the ages of 40 and 70. Bony involvement was common (maxillary and mandibular involvement), though more rarely the salivary glands or mucosa were involved, presenting as a swelling with lysis of underlying bone. Highly malignant varieties (85% of cases) were most commonly encountered. The treatment remains medical, involving chemotherapy (C.H.O.P. or high dose methotrexate) and gives an actuarial survival rate of 50% at 3 years.
Szpirglas
H
H
Service de stomatologie et chirurgie maxillo-faciale, C.H.U. Pitié-Salpêtrière, Paris.
Goudot
P
P
Thomas
A
A
Guilbert
F
F
Vaillant
J M
JM
Touboul
E
E
Nizri
D
D
D000328:Adult; D000368:Aged; D005153:Facial Neoplasms / Q000473:pathology*; D005260:Female; D006801:Humans; D007573:Jaw Neoplasms / Q000473:pathology*; D008228:Lymphoma, Non-Hodgkin / Q000473:pathology*; D008297:Male; D008875:Middle Aged
Lymphomes malins maxillo-faciaux extra-ganglionnaires.